Browse All

Current Filters

CLEAR FILTER x

TITLE

The Effects of Lecanemab Treatment on Soluble CSF Aß Protofibrils (PF) in Clarity AD

Author:Horie, Kanta   Koyama, Akihiko   Sachdev, Pallavi   Shuta, Kazuyoshi   Tahara, Kazuhiro   Kanekiyo, Michio   Dhadda, Shobha   Reyderman, Larisa   Hersch, Steven   Irizarry, Michael   Kramer, Lynn   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S1.003  

Author Institution:Eisai Inc., Nutley, NJ  Eisai Inc., NJ  Eisai Co. Ltd., Japan  

Clinical Profile for Lecanemab Subcutaneous Formulation for Treatment Initiation and Maintenance in Early Alzheimer’s Disease (AD)

Author:Cohen, Sharon   Hersch, Steven   Penner, Natasha   Bhagunde, Pratik   Reyderman, Larisa   Patten, Anna   Dhadda, Shobha   Irizarry, Michael   Kramer, Lynn   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S1.004  

Author Institution:Toronto Memory Program, North York, ON, Canada  Eisai Inc., Nutley, NJ  Eisai Inc., NJ  Eisai, NJ  

The Lecanemab Clarity AD Open-label Extension in Early Alzheimer’s Disease: Initial Findings from the 48-month Analysis

Author:van Dyck, Christopher   Sperling, Reisa   Li, David   Kanekiyo, Michio   Dhadda, Shobha   Hersch, Steven   Gee, Michelle   Irizarry, Michael   Kramer, Lynn   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S1.005  

Author Institution:Yale School of Medicine, New Haven, CT  Brigham and Women'S Hospital, Boston, MA  Eisai, NJ  Eisai Inc., NJ  Eisai Inc., Nutley, NJ  Eisai Ltd, United Kingdom  

Estimating the 10-Year Time-savings Benefits of Lecanemab Treatment

Author:Whetten, John   Dickson, Samuel   Duncan, Garrett   Hendrix, Suzanne   Youmans-Kidder, Katherine   Jones, Daryl   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S1.006  

Author Institution:Pentara Corporation, Millcreek, UT  Eisai Inc., Chicago, IL  Eisai Inc., Nutley, NJ  

Real-world Delays in Anti-amyloid Therapy Initiation Following Diagnosis of Early-stage Alzheimer’s Disease

Author:Rosenbloom, Michael   Singh, Divya   Schnee, Andrea   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S1.007  

Author Institution:University of Washington, Burien, WA  University of Washington, WA